<DOC>
	<DOCNO>NCT02031003</DOCNO>
	<brief_summary>- The primary objective study compare stool composition ( stool soap non-soap fatty acid , total fatty acid , mineral , stool constituent ) infant randomize receive either standard formula , 1 2 innovative formula contain new fat blend new fat blend plus fiber . - The secondary objective evaluate among feed group , stool characteristic ( stool consistency frequency ) , GI tolerance assess Infant Gastrointestinal Symptom Questionnaire ( IGSQ ) , urinary marker ( F2-isoprostanes 8-hydroxy-2'-deoxyguanosine [ 8-OHdG ] , urine osmolality specific gravity ) . - The primary safety objective describe frequency adverse event ( AEs ) among formula-fed ( FF ) group . - The secondary safety objective describe anthropometric measure ( weight , length , head circumference ) among feed group .</brief_summary>
	<brief_title>Effect Infant Formulas Containing New Fat Blend New Fat Blend Plus Fiber Healthy Term Infants</brief_title>
	<detailed_description />
	<criteria>Healthy , term ( le 37 week great 42 week ) singleton infant ; 25 day 45 day post natal age ( date birth = Day 0 ) weight age ≥3rd ≤97th percentiles accord Taiwan growth chart time study entry . Human milk fed infant exclusively consume tolerate HM mother must make decision continue exclusively breastfeed . Formulafed infants exclusively consume tolerate cow 's milk infant formula parents/LAR must previously make decision continue exclusively formula feed . Infants receive amount supplemental HM infant formula feed vice versa Family history sibling document cow 's milk protein intolerance/allergy Major congenital malformation , suspect documented systemic congenital infection , evidence systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>45 Days</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>